Abstract
Successful hepatocyte isolation is critical for continued development of cellular transplantation. However, most tissue available for research is from diseased liver and the results of hepatocyte isolation from such tissue are inferior compared to normal tissue. Here we describe a modified method, combining the use of Liberase and N-acetylcysteine (NAC), for the isolation of primary human hepatocytes with high viability from normal and diseased liver.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Houlihan DD, Newsome PN (2008) Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology 135(2):438–450
Forbes SJ, Newsome PN (2012) New horizons for stem cell therapy in liver disease. J Hepatol 56(2):496–499
Piscaglia AC, Campanale M, Gasbarrini A, Gasbarrini G (2010) Stem cell-based therapies for liver diseases: state of the art and new perspectives. Stem Cells Int 2010:259461
Siniscalco D, Pandolfi A, Galderisi U (2012) State-of-the-art on basic and applied stem cell therapy; Stem Cell Research Italy-International Society for Cellular Therapy Europe, Joint Meeting, Montesilvano (PE)-Italy, June 10–12, 2011. Stem Cells Dev 21(5):668–669
Oertel M, Shafritz DA (2008) Stem cells, cell transplantation and liver repopulation. Biochim Biophys Acta 1782(2):61–74
Thomas JA, Forbes SJ (2009) A fat chance for hepatocyte transplantation? Gut 58(4):480–482
Strom S, Fisher R (2003) Hepatocyte transplantation: new possibilities for therapy. Gastroenterology 124(2):568–571
Lo B, Parham L (2009) Ethical issues in stem cell research. Endocr Rev 30(3):204–213
Tsiaoussis J, Newsome PN, Nelson LJ, Hayes PC, Plevris JN (2001) Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems. Liver Transpl 7(1):2–10
Fitzpatrick E, Mitry RR, Dhawan A (2009) Human hepatocyte transplantation: state of the art. J Intern Med 266(4):339–357
Dhawan A, Strom SC, Sokal E, Fox IJ (2010) Human hepatocyte transplantation. Methods Mol Biol 640:525–534
Puppi J, Strom SC, Hughes RD, Bansal S, Castell JV, Dagher I, Ellis EC, Nowak G, Ericzon BG, Fox IJ, Gomez-Lechon MJ, Guha C, Gupta S, Mitry RR, Ohashi K, Ott M, Reid LM, Roy-Chowdhury J, Sokal E, Weber A, Dhawan A (2012) Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplant 21(1):1–10
Dhawan A, Puppi J, Hughes RD, Mitry RR (2010) Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol 7(5):288–298
Li AP (2007) Human hepatocytes: isolation, cryopreservation and applications in drug development. Chem Biol Interact 168(1):16–29
LeCluyse EL, Alexandre E (2010) Isolation and culture of primary hepatocytes from resected human liver tissue. Methods Mol Biol 640:57–82
Alexandrova K, Griesel C, Barthold M, Heuft HG, Ott M, Winkler M, Schrem H, Manns MP, Bredehorn T, Net M, Vidal MM, Kafert-Kasting S, Arseniev L (2005) Large-scale isolation of human hepatocytes for therapeutic application. Cell Transplant 14(10):845–853
Hughes RD, Mitry RR, Dhawan A, Lehec SC, Girlanda R, Rela M, Heaton ND, Muiesan P (2006) Isolation of hepatocytes from livers from non-heart-beating donors for cell transplantation. Liver Transpl 12(5):713–717
Kawahara T, Toso C, Douglas DN, Nourbakhsh M, Lewis JT, Tyrrell DL, Lund GA, Churchill TA, Kneteman NM (2010) Factors affecting hepatocyte isolation, engraftment, and replication in an in vivo model. Liver Transpl 16(8):974–982
Vondran FW, Katenz E, Schwartlander R, Morgul MH, Raschzok N, Gong X, Cheng X, Kehr D, Sauer IM (2008) Isolation of primary human hepatocytes after partial hepatectomy: criteria for identification of the most promising liver specimen. Artif Organs 32(3):205–213
Bhogal RH, Hodson J, Bartlett DC, Weston CJ, Curbishley SM, Haughton E, Williams KT, Reynolds GM, Newsome PN, Adams DH, Afford SC (2011) Isolation of primary human hepatocytes from normal and diseased liver tissue: a one hundred liver experience. PLoS One 6(3):e18222
Linetsky E, Selvaggi G, Bottino R, Kong SS, Qian T, Alejandro R, Ricordi C (1995) Comparison of collagenase type P and Liberase during human islet isolation using the automated method. Transplant Proc 27(6):3264
Linetsky E, Bottino R, Lehmann R, Alejandro R, Inverardi L, Ricordi C (1997) Improved human islet isolation using a new enzyme blend, Liberase. Diabetes 46(7):1120–1123
Brandhorst H, Brandhorst D, Hering BJ, Bretzel RG (1999) Significant progress in porcine islet mass isolation utilizing liberase HI for enzymatic low-temperature pancreas digestion. Transplantation 68(3):355–361
Donini A, Baccarani U, Lavaroni S, Dialti V, Adami V, Risaliti A, Cautero N, Degrassi A, Bresadola F (2001) Liberase HI enzyme versus collagenase type P for porcine hepatocyte isolation. Transplant Proc 33(1–2):1972–1973
Atkinson MC (2002) The use of N-acetylcysteine in intensive care. Crit Care Resusc 4(1):21–27
Zwingmann C, Bilodeau M (2006) Metabolic insights into the hepatoprotective role of N-acetylcysteine in mouse liver. Hepatology 43(3):454–463
Dunne JB, Davenport M, Williams R, Tredger JM (1994) Evidence that S-adenosylmethionine and N-acetylcysteine reduce injury from sequential cold and warm ischemia in the isolated perfused rat liver. Transplantation 57(8):1161–1168
Fukuzawa K, Emre S, Senyuz O, Acarli K, Schwartz ME, Miller CM (1995) N-acetylcysteine ameliorates reperfusion injury after warm hepatic ischemia. Transplantation 59(1):6–9
Fusai G, Glantzounis GK, Hafez T, Yang W, Quaglia A, Sheth H, Kanoria S, Parkes H, Seifalian A, Davidson BR (2005) N-Acetylcysteine ameliorates the late phase of liver ischaemia/reperfusion injury in the rabbit with hepatic steatosis. Clin Sci (Lond) 109(5):465–473
Sagias FG, Mitry RR, Hughes RD, Lehec SC, Patel AG, Rela M, Mieli-Vergani G, Heaton ND, Dhawan A (2010) N-Acetylcysteine improves the viability of human hepatocytes isolated from severely steatotic donor liver tissue. Cell Transplant 19(11):1487–1492
Bartlett DC, Hodson J, Bhogal RH, Youster J, Newsome PN (2014) Combined use of N-acetylcysteine and Liberase improves the viability and metabolic function of human hepatocytes isolated from human liver. Cytotherapy 16(6):800–809
Pichard L, Raulet E, Fabre G, Ferrini JB, Ourlin JC, Maurel P (2006) Human hepatocyte culture. Methods Mol Biol 320:283–293
Acknowledgment
This work was supported by the Medical Research Council.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Bartlett, D.C., Newsome, P.N. (2017). A Modified Protocol for the Isolation of Primary Human Hepatocytes with Improved Viability and Function from Normal and Diseased Human Liver. In: Stock, P., Christ, B. (eds) Hepatocyte Transplantation. Methods in Molecular Biology, vol 1506. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6506-9_4
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6506-9_4
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6504-5
Online ISBN: 978-1-4939-6506-9
eBook Packages: Springer Protocols